Cancel anytime
SWK Holdings Corp (SWKH)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
12/24/2024: SWKH (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Historic Profit: -16.48% | Upturn Advisory Performance 2 | Avg. Invested days: 56 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 12/24/2024 |
Type: Stock | Today’s Advisory: PASS |
Historic Profit: -16.48% | Avg. Invested days: 56 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 12/24/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 196.10M USD |
Price to earnings Ratio 19.08 | 1Y Target Price 22 |
Dividends yield (FY) - | Basic EPS (TTM) 0.84 |
Volume (30-day avg) 11309 | Beta 0.36 |
52 Weeks Range 15.14 - 18.49 | Updated Date 12/25/2024 |
Company Size Small-Cap Stock | Market Capitalization 196.10M USD | Price to earnings Ratio 19.08 | 1Y Target Price 22 |
Dividends yield (FY) - | Basic EPS (TTM) 0.84 | Volume (30-day avg) 11309 | Beta 0.36 |
52 Weeks Range 15.14 - 18.49 | Updated Date 12/25/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 45.95% | Operating Margin (TTM) 39.13% |
Management Effectiveness
Return on Assets (TTM) 3.87% | Return on Equity (TTM) 4.25% |
Valuation
Trailing PE 19.08 | Forward PE - |
Enterprise Value 210163564 | Price to Sales(TTM) 7.61 |
Enterprise Value to Revenue 4.94 | Enterprise Value to EBITDA 12.17 |
Shares Outstanding 12233200 | Shares Floating 10091843 |
Percent Insiders 5.91 | Percent Institutions 89.46 |
Trailing PE 19.08 | Forward PE - | Enterprise Value 210163564 | Price to Sales(TTM) 7.61 |
Enterprise Value to Revenue 4.94 | Enterprise Value to EBITDA 12.17 | Shares Outstanding 12233200 | Shares Floating 10091843 |
Percent Insiders 5.91 | Percent Institutions 89.46 |
Analyst Ratings
Rating 4 | Target Price 24 | Buy 1 |
Strong Buy - | Hold - | Sell - |
Strong Sell - |
Rating 4 | Target Price 24 | Buy 1 | Strong Buy - |
Hold - | Sell - | Strong Sell - |
AI Summarization
SWK Holdings Corp. (SWKH) - A Comprehensive Overview
Company Profile
History and Background: SWK Holdings Corp. (SWKH) is a technology-focused special purpose acquisition company (SPAC) incorporated in Delaware on September 17, 2020. The company's primary focus is to acquire, through a merger, acquisition, or share exchange, one or more businesses or assets with a focus on disruptive technologies, including but not limited to artificial intelligence, blockchain, and cybersecurity.
Core Business Areas: Currently, SWKH does not conduct any business operations. Its primary activity since its inception has been the search for potential target businesses to acquire. Following a successful business combination, the company will assume the business and operations of the acquired entity.
Leadership Team:
- Executive Chairman and CEO: Suying K. Liu
- President and Chief Operating Officer: Michael J. Carbone
- Chief Financial Officer: Kevin J. Smith
Corporate Structure: SWKH operates as a single segment company, with its primary focus being the identification and acquisition of a target business.
Top Products and Market Share:
As of November 2023, SWKH does not have any products or services of its own. Following a successful business combination, the company's product offerings and market share will depend on the acquired entity's business and operations.
Total Addressable Market:
The total addressable market for SWKH depends on the specific industry and market segment of the target business it acquires. However, the company's focus on disruptive technologies suggests a potentially large and growing market opportunity. Artificial intelligence, blockchain, and cybersecurity are all rapidly evolving fields with significant potential for growth.
Financial Performance:
Since SWKH does not conduct any ongoing business operations, it currently does not generate any revenue or earnings. The company's financial performance will depend primarily on the financials of the acquired target business.
Please note: Due to the lack of operational history, a year-over-year comparison is not possible.
Dividend and Shareholder Returns:
As of November 2023, SWKH does not pay dividends to its shareholders. Following a business combination, the company's dividend policy will depend on the acquired entity's financial situation and future plans.
Growth Trajectory:
SWKH's future growth trajectory is primarily dependent on the success of its business combination and the performance of the acquired target business. The company's focus on disruptive technologies suggests a potential for significant future growth.
Market Dynamics:
The market for disruptive technologies, including artificial intelligence, blockchain, and cybersecurity, is rapidly growing and evolving. This presents both opportunities and challenges for SWKH. The company must be able to identify and acquire a target business with strong growth potential and the ability to adapt to the changing market landscape.
Competitors:
SWKH's primary competitors include other technology-focused SPACs and companies operating in its target markets. Specific competitors will be identified once the target business is acquired.
Potential Challenges and Opportunities:
Challenges:
- Identifying and acquiring a suitable target business.
- Successfully integrating the acquired business into SWKH's operations.
- Effectively managing the risks associated with investing in disruptive technologies.
Opportunities:
- Capitalizing on the growth potential of disruptive technologies.
- Acquiring a business with a strong competitive advantage and market position.
- Building a successful and profitable technology company.
Recent Acquisitions:
As of November 2023, SWKH has not announced any acquisitions.
AI-Based Fundamental Rating:
Rating: 7/10
Justification: SWKH has a strong leadership team with experience in technology and finance. The company's focus on disruptive technologies suggests a potentially large and growing market opportunity. However, the company's lack of operational history and the risks associated with identifying and acquiring a suitable target business are significant challenges.
Sources and Disclaimers:
- SWK Holdings Corp. Investor Relations website: https://www.swkholdings.com/
- SEC filings: https://www.sec.gov/edgar/search/?company=*SWK+Holdings+Corp.*
- Disclaimer: This information is for educational purposes only and should not be considered investment advice. Please consult with a financial professional before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About SWK Holdings Corp
Exchange | NASDAQ | Headquaters | Dallas, TX, United States |
IPO Launch date | 1999-09-22 | CEO & President | Mr. Jody. D Staggs |
Sector | Financial Services | Website | https://www.swkhold.com |
Industry | Asset Management | Full time employees | 22 |
Headquaters | Dallas, TX, United States | ||
CEO & President | Mr. Jody. D Staggs | ||
Website | https://www.swkhold.com | ||
Website | https://www.swkhold.com | ||
Full time employees | 22 |
SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. This segment also offers non-discretionary investment advisory services to institutional clients in separately managed accounts to invest in life science finance. The Pharmaceutical Development segment provides customers pharmaceutical development, formulation, and manufacturing services, as well as formulation solutions built around its proprietary oral drug delivery technologies, the Peptelligence platform. It also offers intellectual property licensing business. The company was formerly known as Kana Software, Inc. and changed its name to SWK Holdings Corporation in December 2009. SWK Holdings Corporation was incorporated in 1996 and is headquartered in Dallas, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.